Topics

Exosome redux. Adult stem cell companies are pivoting their businesses to commercialize exosomes as therapeutics - @MarkZipkin https://go.nature.com/2RumZG3 pic.twitter.com/6ZmYOvjmfq

09:24 EST 4 Dec 2019 | Nature Publishing

Exosome redux. Adult stem cell companies are pivoting their businesses to commercialize exosomes as therapeutics - https://go.nature.com/2RumZG3 

Original Article: Exosome redux. Adult stem cell companies are pivoting their businesses to commercialize exosomes as therapeutics - @MarkZipkin https://go.nature.com/2RumZG3 pic.twitter.com/6ZmYOvjmfq

NEXT ARTICLE

More From BioPortfolio on "Exosome redux. Adult stem cell companies are pivoting their businesses to commercialize exosomes as therapeutics - @MarkZipkin https://go.nature.com/2RumZG3 pic.twitter.com/6ZmYOvjmfq"

Quick Search

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...